CNS Pharmaceuticals to appoint Amy Mahery as independent director upon financing close

CNS Pharmaceuticals, Inc.

Amy Mahery appointed as independent Board member effective upon completion of Company's financing.
She will not serve on any Board committees initially.
Compensation will follow standard non-employee director program as previously disclosed.
No other changes to Board or management.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amy Mahery

Director

CNSP · CNS Pharmaceuticals, Inc.

Filed: January 23, 2024, 6:59 PM ET

On January 17, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) agreed to appoint Amy Mahery as an independent member of the Company’s Board of Directors effective upon the completion of the Company’s financing.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amy Mahery was appointed as Director at CNS Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

On January 17, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) agreed to appoint Amy Mahery as an independent member of the Company’s Board of Directors effective upon the completion of the Company’s financing.

View on SEC.gov

CNS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-24-000393

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.